The Prospects for “Personalized Medicine” in Drug Development and Drug Therapy View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2007-02

AUTHORS

J Woodcock

ABSTRACT

There has been much recent discussion about the advent of "personalized medicine," but controversy exists over its exact definition; how, when, and whether it will be brought about, and what means could be used to measure its attainment. In fact, the concept of "personalized medicine" is a sort of shorthand used to represent the logical next steps in progression of medical science toward greater mechanistic understanding of health, disease, and treatment. This shorthand is attractive to the public because of its intuitive appeal, and irritating to the biomedical community because it glosses over the very real scientific and implementation challenges. This paper evaluates the trajectory and promise of these next steps for the currently problematic states of both drug development and therapy. More... »

PAGES

164-169

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.clpt.6100063

DOI

http://dx.doi.org/10.1038/sj.clpt.6100063

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1001636899

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/17259943


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2202", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "History and Philosophy of Specific Fields", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/22", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Philosophy and Religious Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Approval", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Design", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Industry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Forecasting", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient-Centered Care", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "United States Food and Drug Administration", 
          "id": "https://www.grid.ac/institutes/grid.417587.8", 
          "name": [
            "Deputy Commissioner for Operations, Food and Drug Administration Rockville Maryland USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Woodcock", 
        "givenName": "J", 
        "id": "sg:person.01107576476.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107576476.16"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2007-02", 
    "datePublishedReg": "2007-02-01", 
    "description": "There has been much recent discussion about the advent of \"personalized medicine,\" but controversy exists over its exact definition; how, when, and whether it will be brought about, and what means could be used to measure its attainment. In fact, the concept of \"personalized medicine\" is a sort of shorthand used to represent the logical next steps in progression of medical science toward greater mechanistic understanding of health, disease, and treatment. This shorthand is attractive to the public because of its intuitive appeal, and irritating to the biomedical community because it glosses over the very real scientific and implementation challenges. This paper evaluates the trajectory and promise of these next steps for the currently problematic states of both drug development and therapy.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.clpt.6100063", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1017409", 
        "issn": [
          "0009-9236", 
          "1532-6535"
        ], 
        "name": "Clinical Pharmacology & Therapeutics", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "81"
      }
    ], 
    "name": "The Prospects for \u201cPersonalized Medicine\u201d in Drug Development and Drug Therapy", 
    "pagination": "164-169", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "07cc025cf6e2cbdf136af1f95369f5d49864f8f6b41609a988b55eb4a826ea96"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "17259943"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0372741"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.clpt.6100063"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1001636899"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.clpt.6100063", 
      "https://app.dimensions.ai/details/publication/pub.1001636899"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T16:56", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8672_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://onlinelibrary.wiley.com/doi/10.1038/sj.clpt.6100063/abstract"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.clpt.6100063'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.clpt.6100063'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.clpt.6100063'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.clpt.6100063'


 

This table displays all metadata directly associated to this object as RDF triples.

97 TRIPLES      20 PREDICATES      36 URIs      28 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.clpt.6100063 schema:about N12624502ed914ba594741d2519d48906
2 N2209e0da66484afd93a68014dc38c995
3 N34f4e7b1d98e40f583eec471779e81b2
4 N64be886035104e16bc479b65ffb33d3a
5 N7c595139eb2a4ed1ae439337f7f6e3ec
6 N853f2430192a404cb2936a5a76b404cb
7 Nb32be80bcc5c4887b32bd5e1b7f65ec2
8 anzsrc-for:22
9 anzsrc-for:2202
10 schema:author N298ba74163f94aae9c625f2c9c9688d1
11 schema:datePublished 2007-02
12 schema:datePublishedReg 2007-02-01
13 schema:description There has been much recent discussion about the advent of "personalized medicine," but controversy exists over its exact definition; how, when, and whether it will be brought about, and what means could be used to measure its attainment. In fact, the concept of "personalized medicine" is a sort of shorthand used to represent the logical next steps in progression of medical science toward greater mechanistic understanding of health, disease, and treatment. This shorthand is attractive to the public because of its intuitive appeal, and irritating to the biomedical community because it glosses over the very real scientific and implementation challenges. This paper evaluates the trajectory and promise of these next steps for the currently problematic states of both drug development and therapy.
14 schema:genre research_article
15 schema:inLanguage en
16 schema:isAccessibleForFree false
17 schema:isPartOf N3ef2c46290aa44c4ab47edfd01be30b2
18 Ne60ebc68153a4fc7872e5987620e3d30
19 sg:journal.1017409
20 schema:name The Prospects for “Personalized Medicine” in Drug Development and Drug Therapy
21 schema:pagination 164-169
22 schema:productId N3bc3c08ea8664ecb82d6a0771111993d
23 N71e8bc9fc1cb4b04b89f8e26f3c83449
24 Na0aa267d58664086a184e43f29611bec
25 Nbd1b431f1c6240ba91f9338c90f53dec
26 Nbd34994a476147df951c3896812b80dc
27 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001636899
28 https://doi.org/10.1038/sj.clpt.6100063
29 schema:sdDatePublished 2019-04-10T16:56
30 schema:sdLicense https://scigraph.springernature.com/explorer/license/
31 schema:sdPublisher N95a4a302bfaf48f1bc99a93bd3b3c8f8
32 schema:url http://onlinelibrary.wiley.com/doi/10.1038/sj.clpt.6100063/abstract
33 sgo:license sg:explorer/license/
34 sgo:sdDataset articles
35 rdf:type schema:ScholarlyArticle
36 N12624502ed914ba594741d2519d48906 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
37 schema:name Forecasting
38 rdf:type schema:DefinedTerm
39 N2209e0da66484afd93a68014dc38c995 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
40 schema:name Drug Therapy
41 rdf:type schema:DefinedTerm
42 N298ba74163f94aae9c625f2c9c9688d1 rdf:first sg:person.01107576476.16
43 rdf:rest rdf:nil
44 N34f4e7b1d98e40f583eec471779e81b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
45 schema:name Humans
46 rdf:type schema:DefinedTerm
47 N3bc3c08ea8664ecb82d6a0771111993d schema:name nlm_unique_id
48 schema:value 0372741
49 rdf:type schema:PropertyValue
50 N3ef2c46290aa44c4ab47edfd01be30b2 schema:issueNumber 2
51 rdf:type schema:PublicationIssue
52 N64be886035104e16bc479b65ffb33d3a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
53 schema:name Drug Industry
54 rdf:type schema:DefinedTerm
55 N71e8bc9fc1cb4b04b89f8e26f3c83449 schema:name dimensions_id
56 schema:value pub.1001636899
57 rdf:type schema:PropertyValue
58 N7c595139eb2a4ed1ae439337f7f6e3ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
59 schema:name Drug Approval
60 rdf:type schema:DefinedTerm
61 N853f2430192a404cb2936a5a76b404cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
62 schema:name Patient-Centered Care
63 rdf:type schema:DefinedTerm
64 N95a4a302bfaf48f1bc99a93bd3b3c8f8 schema:name Springer Nature - SN SciGraph project
65 rdf:type schema:Organization
66 Na0aa267d58664086a184e43f29611bec schema:name pubmed_id
67 schema:value 17259943
68 rdf:type schema:PropertyValue
69 Nb32be80bcc5c4887b32bd5e1b7f65ec2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Drug Design
71 rdf:type schema:DefinedTerm
72 Nbd1b431f1c6240ba91f9338c90f53dec schema:name readcube_id
73 schema:value 07cc025cf6e2cbdf136af1f95369f5d49864f8f6b41609a988b55eb4a826ea96
74 rdf:type schema:PropertyValue
75 Nbd34994a476147df951c3896812b80dc schema:name doi
76 schema:value 10.1038/sj.clpt.6100063
77 rdf:type schema:PropertyValue
78 Ne60ebc68153a4fc7872e5987620e3d30 schema:volumeNumber 81
79 rdf:type schema:PublicationVolume
80 anzsrc-for:22 schema:inDefinedTermSet anzsrc-for:
81 schema:name Philosophy and Religious Studies
82 rdf:type schema:DefinedTerm
83 anzsrc-for:2202 schema:inDefinedTermSet anzsrc-for:
84 schema:name History and Philosophy of Specific Fields
85 rdf:type schema:DefinedTerm
86 sg:journal.1017409 schema:issn 0009-9236
87 1532-6535
88 schema:name Clinical Pharmacology & Therapeutics
89 rdf:type schema:Periodical
90 sg:person.01107576476.16 schema:affiliation https://www.grid.ac/institutes/grid.417587.8
91 schema:familyName Woodcock
92 schema:givenName J
93 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107576476.16
94 rdf:type schema:Person
95 https://www.grid.ac/institutes/grid.417587.8 schema:alternateName United States Food and Drug Administration
96 schema:name Deputy Commissioner for Operations, Food and Drug Administration Rockville Maryland USA
97 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...